Multiple Sclerosis Research Today is a free monthly online journal that collates and summarizes the latest research about Multiple Sclerosis, including details on diagnosis, symptoms, treatment, prognosis.

Volume 2 (2005), Issue 7 (July)

1. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
   Neuroimmunomodulation, 12(4): 220-34. [Abstract] [Full-text]
2. Multiple sclerosis coinciding with Machado-Joseph disease.
   Neurol Sci, 26(2): 135-6. [Abstract] [Full-text]
3. MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis.
   J Neurol Sci, 234(1): 17-24. [Abstract] [Full-text]
4. Multiple sclerosis in Iraq: does it have the same features encountered in Western countries?
   J Neurol Sci, 234(1): 67-71. [Abstract] [Full-text]
5. Pilot study to examine the effect of antibiotic therapy on MRI outcomes in RRMS.
   J Neurol Sci, 234(1): 87-91. [Abstract] [Full-text]
6. A PD-1 polymorphism is associated with disease progression in multiple sclerosis.
   Ann Neurol, 58(1): 50-7. [Abstract] [Full-text]
7. Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression.
   Clin Exp Immunol, 141(2): 326-32. [Abstract] [Full-text]
8. Interferon beta in relapsing-remitting multiple sclerosis. An eight years experience in a specialist multiple sclerosis centre.
   J Neurol, 252(7): 795-800. [Abstract] [Full-text]
9. Proton magnetic resonance spectroscopy of normal appearing white matter in familial and sporadic multiple sclerosis.
   J Neurol, 252(7): 830-2. [Abstract] [Full-text]
10. Long-term exercise improves functional impairment but not quality of life in multiple sclerosis.
    J Neurol, 252(7): 839-45. [Abstract] [Full-text]
11. Corticomotor organisation and motor function in multiple sclerosis.
    J Neurol, 252(7): 765-71. [Abstract] [Full-text]
12. Discriminant analysis of the cognitive performance profile of MS patients differentiates their clinical course.
    J Neurol, 252(7): 808-13. [Abstract] [Full-text]
13. CSF pleocytosis and expansion of spinal lesions in Japanese multiple sclerosis with special reference to the new diagnostic criteria.
    J Neurol, 252(7): 824-9. [Abstract] [Full-text]
14. Long-term follow-up of 106 multiple sclerosis patients undergoing interferon-beta 1a or 1b therapy: predictive factors of thyroid disease development and duration.
    J Clin Endocrinol Metab, 90(7): 4133-7. [Abstract] [Full-text]
15. E-selectin A561C and G98T polymorphisms influence susceptibility and course of multiple sclerosis.
    J Neuroimmunol, 165(1): 201-5. [Abstract] [Full-text]
16. Effective combination of minocycline and interferon-beta in a model of multiple sclerosis.
    J Neuroimmunol, 165(1): 83-91. [Abstract] [Full-text]
17. Immunological patterns identifying disease course and evolution in multiple sclerosis patients.
    J Neuroimmunol, 165(1): 192-200. [Abstract] [Full-text]
18. Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis.
    J Neuroimmunol, 165(1): 41-52. [Abstract] [Full-text]
19. Hypothalamo-pituitary-adrenal axis activity predicts disease progression in multiple sclerosis.
    J Neuroimmunol, 165(1): 186-91. [Abstract] [Full-text]
20. Impact of the Asp299Gly polymorphism in the toll-like receptor 4 (tlr-4) gene on disease course of multiple sclerosis.
    J Neuroimmunol, 165(1): 161-5. [Abstract] [Full-text]
21. Modality-specific aspects of sustained and divided attentional performance in multiple sclerosis.
    Arch Clin Neuropsychol, 20(6): 705-18. [Abstract] [Full-text]
22. Multiple sclerosis and hepatitis B vaccination: could minute contamination of the vaccine by partial hepatitis B virus polymerase play a role through molecular mimicry?
    Med Hypotheses, 65(3): 509-20. [Abstract] [Full-text]
23. Repopulation of oligodendrocyte progenitor cell-depleted tissue in a model of chronic demyelination.
    Neuropathol Appl Neurobiol, 31(4): 374-83. [Abstract] [Full-text]
24. Relevance of immunological variables in neuroborreliosis and multiple sclerosis.
    Acta Neurol Scand, 112(2): 97-102. [Abstract] [Full-text]
25. Kynurenine metabolism in multiple sclerosis.
    Acta Neurol Scand, 112(2): 93-6. [Abstract] [Full-text]
26. Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells.
    Eur J Immunol, 35(6): 1786-94. [Abstract] [Full-text]
27. Bovine spongiform encephalopathy, multiple sclerosis, and creutzfeldt-jakob disease are probably autoimmune diseases evoked by Acinetobacter bacteria.
    Ann N Y Acad Sci, 1050: 417-28. [Abstract] [Full-text]
28. Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-beta.
    J Interferon Cytokine Res, 25(7): 395-406. [Abstract] [Full-text]
29. An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis.
    Proc Natl Acad Sci U S A, 102(29): 10273-8. [Abstract] [Full-text]
30. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
    Brain, 128: 1747-63. [Abstract] [Full-text]
31. Determination of multiple sclerosis plaque size with diffusion-tensor MR Imaging: comparison study with healthy volunteers.
    Radiology, 236(2): 615-20. [Abstract] [Full-text]
32. The activation of memory CD4(+) T cells and CD8(+) T cells in patients with multiple sclerosis.
    J Neurol Sci, 235(1): 11-7. [Abstract] [Full-text]
33. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis.
    N Engl J Med, 353(4): 369-74. [Abstract] [Full-text]
34. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab.
    N Engl J Med, 353(4): 375-81. [Abstract] [Full-text]

© 2004-2010 Multiple Sclerosis Research Today. All Rights Reserved.